Abstract
The mechanisms underlying the circadian rhythm of the toxicity induced by irinotecan hydrochloride (CPT-11; 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin) were investigated from the viewpoint of the sensitivity of living organisms and the pharmacokinetics of the drug. ICR male mice were housed under standardized light-dark cycle conditions (lights on at 0700, off at 1900) with food and water ad libitum. The loss of body weight after an intraperitoneal injection of CPT-11 (100 mg/kg) was more serious in the late dark and the early light and milder in the late light and the early dark. The CPT-11-induced leukopenia was more serious in the late dark and milder in the late light. The lower toxicity of CPT-11 was observed when DNA synthesis and type I DNA topoisomerase activity in bone marrow cells decreased and the higher toxicity was observed when these activities began to increase. There were circadian stage-dependent changes in the concentrations of CPT-11 and its major metabolite (SN-38; 7-ethyl-10-hydroxycamptothecin) in plasma. The higher concentrations of CPT-11 and SN-38 in plasma were observed when the level of CPT-11-induced toxicity increased. The present study suggests that the toxicity of CPT-11 is influenced by circadian rhythm-dependent processes.
Footnotes
-
Send reprint requests to: Shigehiro Ohdo, Ph.D., Department of Clinical Pharmacokinetics, Division of Pharmaceutical Science, Kyushu University, 3–1-1, Maidashi, Higashi-Ku, Fukuoka, 812 Japan.
- Abbreviations:
- CPT
- camptothecin
- CPT-11
- irinotecan hydrochloride, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin
- SN-38
- 7-ethyl-10-hydroxycamptothecin
- Topo I
- type I DNA topoisomerase
- HPLC
- high pressure liquid chromatography
- AUC
- area under the plasma-time concentration curve
- MRT
- mean residence time
- VRT
- variance of residence time
- EDTA
- ethylenediaminetetraacetic acid
- I.D.
- internal diameter
- Received April 29, 1997.
- Accepted August 11, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|